Skip to content

Serum Autologous Therapy in Idiopathic Chronic Urticaria

Effects of Serum Autologous Therapy in patients with Idiopathic Chronic Urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171222037986N2
Enrollment
64
Registered
2019-01-15
Start date
2014-09-22
Completion date
Unknown
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Chronic Urticaria. Urticaria, unspecified

Interventions

Intervention 1: Intervention group: Patients with chronic idiopathic urticaria - 5 cc blood is taken from the brachial vein and centrifuged at 2000 rpm 2.5 cc of the patient's serum will be injected d

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: History of hives at least 6 weeks

Exclusion criteria

Exclusion criteria: Finding a specific cause (physical urticaria) Pregnancy Lactation Don't use a safe contraceptive method Severe systemic illness Taking anticoagulant drugs Taking systemic corticosteroids during the last 6 weeks Taking immuno suppressor drugs during the last 6 weeks

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: Weekly to Week 9, Week 12 and Week 16. Method of measurement: SF-36 quality of life questionnaire.;Hives severity. Timepoint: Weekly to Week 9, Week 12 and Week 16. Method of measurement: Urticaria Activity score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasol Nasiri Kalmarzi

Sanandaj University of Medical Sciences

rnasiri@Razi.Tums.ac.ir+98 87 3323 0524

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026